Lanzhou Foci Pharmaceutical Co.,Ltd.’s Net Profit Dropped 31.7% in First Three Quarters of 2021

Lanzhou Foci Pharmaceutical Co.,Ltd. (兰州佛慈制药股份有限公司) (002644.SZ) reported a net profit of 73.8 million yuan in the first three quarters of 2021, down 31.7% year-on-year.

Meanwhile, the company posted 664.2 million yuan in revenue, up 32.2% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 746.8 million yuan in total liabilities, with a liability-to-asset ratio of 31.7%.

This article was automatically produced by Caixin Automation on Nov. 3, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.